Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
Berch, Mark (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S282000, C514S259500, C540S579000, C546S244000, C546S115000, C548S267400
Reexamination Certificate
active
11138773
ABSTRACT:
The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
REFERENCES:
patent: 2004/0006065 (2004-01-01), Glunz
patent: WO 2003/035076 (2003-05-01), None
patent: WO 2003/035077 (2003-05-01), None
patent: WO 2004/058756 (2004-07-01), None
patent: WO 2004/058757 (2004-07-01), None
patent: WO 2005/061490 (2005-07-01), None
patent: WO 2005/061501 (2005-07-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Banville Jacques
Matiskella John D.
Naidu B. Narasimhulu
Plamondon Serge
Ueda Yasutsugu
Berch Mark
Bristol--Myers Squibb Company
Epperson James
Moore Susanna
LandOfFree
Bicyclic heterocycles as HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heterocycles as HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocycles as HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893713